Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Immunology
- Vol. 232, 108871
- https://doi.org/10.1016/j.clim.2021.108871
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Humoral Immune Response to SARS-CoV-2 in IcelandThe New England Journal of Medicine, 2020
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansNature Microbiology, 2020
- COVID-19 diagnosis —A review of current methodsBiosensors and Bioelectronics, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patientsScandinavian Journal of Infectious Diseases, 2011
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryThe New England Journal of Medicine, 2007
- Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based modelClinical Immunology, 2007
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006
- Antibody Pharmacokinetics and PharmacodynamicsJournal of Pharmaceutical Sciences, 2004